-
1.
公开(公告)号:US20080176919A1
公开(公告)日:2008-07-24
申请号:US11813063
申请日:2005-12-23
IPC分类号: A61K31/4164 , C07D233/84 , A61P31/18
CPC分类号: C07D233/84
摘要: This invention relates to benzonitrile derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R3 are defined in the description, to their use in medicine, and to compositions containing them. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof.
摘要翻译: 本发明涉及式(I)的苄腈衍生物或其药学上可接受的盐,溶剂合物或衍生物,其中R 1至R 3在本说明书中定义为其使用 在医学中,以及含有它们的组合物。 本发明的化合物与酶逆转录酶结合,是调节剂,特别是其抑制剂。
-
公开(公告)号:US20090264425A1
公开(公告)日:2009-10-22
申请号:US11722181
申请日:2005-12-12
申请人: Lyn Howard Jones , Donald Stuart Middleton , Charles Eric Mowbray , Sandra Dora Newman , David Howard Williams
发明人: Lyn Howard Jones , Donald Stuart Middleton , Charles Eric Mowbray , Sandra Dora Newman , David Howard Williams
IPC分类号: A61K31/5377 , A61K31/497 , A61K31/437 , A61K31/44 , C07D413/12 , C07D403/04 , C07D471/02 , C07D213/04
CPC分类号: C07D215/36 , C07C311/46 , C07D207/12 , C07D207/16 , C07D211/26 , C07D211/42 , C07D213/71 , C07D213/75 , C07D213/89 , C07D215/08 , C07D215/40 , C07D215/48 , C07D231/12 , C07D231/40 , C07D237/20 , C07D239/42 , C07D241/08 , C07D241/20 , C07D261/08 , C07D271/07 , C07D295/185 , C07D413/04 , C07D471/04
摘要: This invention relates to biaryl ether derivatives of formula (I) wherein R1, R3, R4, X, W, Y and m are defined in the description, and to compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof.
摘要翻译: 本发明涉及式(I)的联芳基醚衍生物,其中R 1,R 3,R 4,X,W,Y和m在说明书中定义,以及含有它们的组合物及其衍生物的用途。 本发明的化合物与酶逆转录酶结合,是调节剂,特别是其抑制剂。
-
公开(公告)号:US06770645B2
公开(公告)日:2004-08-03
申请号:US10096190
申请日:2002-03-12
IPC分类号: C07D48704
CPC分类号: C07D487/04
摘要: Compound of general formula I: wherein R1, R2, R3, R4, X, Y and R5 have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.
摘要翻译: 通式I的化合物:其中R 1,R 2,R 3,R 4,X,Y和R 5具有本文给出的用于治疗和预防性治疗 需要抑制环鸟嘌呤3',5'-单磷酸磷酸二酯酶(例如cGMP PDE5)的医疗条件。
-
-